Company News: Sanofi-Aventis, Chattem, Allergan and Pacific Communications

Share this article:
Sanofi-Aventis completed its acquisition of Chattem, strengthening its presence in the US consumer healthcare market and bolstering its OTC switch capabilities. Chattanooga, TN-based Chattem will continue to be led by Zan Guerry, CEO, who will report to Sanofi-Aventis US president and CEO Greg Irace.
 
Allergan
named Pacific Communications agency of record for overactive bladder treatment Sanctura XR. The review resulted from a co-promotion agreement Allergan entered into with Quintiles whereby Quintiles will leverage its expertise in primary care to rapidly deploy a specialized sales for ce for the product while Allergan continues to target urology. Pacific will act as agency of record on both efforts.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.